Tech Company Financing Transactions
Tetra Discovery Partners Funding Round
On 11/30/2016, Tetra Discovery Partners raised $5 million in Series A funding from Apjohn Ventures, Grand Angels and Dolby Family Ventures.
Transaction Overview
Company Name
Announced On
11/30/2016
Transaction Type
Venture Equity
Amount
$5,000,000
Round
Series A
Investors
Proceeds Purpose
We are very pleased to receive this new financing which will enable Tetra to complete the necessary preparations for a planned Phase 2a study of our lead drug candidate, BPN14770, in Alzheimer's disease during the second half of 2017.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
38 Fulton St. W 303
Grand Rapids, MI 49503
USA
Grand Rapids, MI 49503
USA
Phone
Website
Email Address
Overview
Our research focuses on developing new treatments for depression based on subtype-selective modulation of phosphodiesterase 4B (PDE4B). PDE4 in neurons is responsible for the hydrolysis of cAMP. We and our colleagues recently described the protein structure of a key PDE4 regulatory domain known as UCR2.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Gurney
Chief Financial Officer
Harvey Elgersma
Chief Medical Officer
Scott Reines
VP - Bus. Development
Joseph Collard
VP - Regulatory Affairs
Chad Coberly
Browse more venture capital transactions:
Prev: 11/30/2016: Nexosis venture capital transaction
Next: 11/30/2016: Digital Sandbox venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to document tech company VC transactions. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs